Favipiravir is a promising treatment candidate for managing coronavirus disease 2019 (COVID-19). Warfarin has many drug interactions, but no interactions with favipiravir have been reported.

Matéria original


S100A8 may govern hyper-inflammation in severe COVID-19


Remdesivir for the treatment of COVID 19: review of the pharmacological properties, safety and clinical effectiveness